Table 4 Estimated mean logMAR VA of all eyes and in eyes categorized into the non-infectious and infectious uveitis groups.

From: Long-term visual acuity outcome of pediatric uveitis patients presenting with severe visual impairment

 

Baseline

3 months

6 months

12 months

18 months

24 months

36 months

48 months

60 months

Patients, n

50

50

50

45

33

29

22

18

15

Eyes, n

56

56

56

50

38

33

26

22

19

Mean logMAR VA of all eyes (95% CI)a

1.79 (1.59–2.00)

1.29 (1.09–1.50)

1.26 (1.05–1.46)

1.33 (1.12–1.54)

1.30 (1.07–1.52)

1.18 (0.95–1.41)

1.21 (0.96–1.46)

1.07 (0.80–1.33)

1.18 (0.91–1.45)

Mean logMAR VA of eyes with non-infectious uveitis (95% CI)a, n = 38 eyes

1.81 (1.57–2.06)

1.27 (1.03–1.52)

1.24 (1.00–1.49)

1.29 (1.03–1.54)

1.26 (1.00–1.53)

1.17 (0.90–1.45)

1.20 (0.91–1.49)

1.06 (0.77–1.36)

1.21 (0.90–1.52)

Mean logMAR VA of eyes with infectious uveitis (95% CI)a, n = 19 eyes

1.75 (1.39–2.11)

1.33 (0.97–1.69)

1.28 (0.92–1.64)

1.42 (1.06–1.79)

1.38 (0.95–1.81)

1.18 (0.74–1.63)

1.22 (0.74–1.71)

1.01 (0.38–1.64)

0.98 (0.35–1.61)

P-valueb

0.777

0.808

0.862

0.555

0.643

0.964

0.928

0.880

0.518

  1. CI confidence interval, logMAR logarithm of the minimum angle of resolution, VA visual acuity.
  2. aDerived from mixed-effects random intercept linear regression model.
  3. bP-value of Wald test comparing VA at each timepoint between the non-infectious and infectious uveitis groups.
Back to article page